Tefludazine

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C22H24F4N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2XUS19W8FE, chemically known as 1-piperazineethanol, 4-(3-(4-fluorophenyl)-2,3-dihydro-6-(trifluoromethyl)-1h-indel-1-yl)-, trans-(+-)- but generally known as tefludazine, which bears US NIH Compound Identifier 71240. European Medicines Agency schedules Tefludazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10867MIG. The term TEFLUDAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). TEFLUDAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tefludazine under HS 29335995 and SITC 51576. As of Q4 2014, TEFLUDAZINE remains the US FDA Preferred Term for this commodity. Tefludazine bears US NLM identifiers UMLS ID C0245303 and NCI Concept Code C90626. SMILES: FC(F)(F)C1CC2C(N3CCN(CC3)CCO)CC(C2CC1)C1CCC(F)CC1.